A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
about
Recent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsCurrent clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer.
P2860
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@en
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@nl
type
label
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@en
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@nl
prefLabel
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@en
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@nl
P2093
P2860
P1433
P1476
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
@en
P2093
Boone Goodgame
Jeffrey Bradley
Kristina Williams
Melissa Rooney
Ramaswamy Govindan
Saiama N Waqar
P2860
P304
P356
10.1016/J.CLLC.2013.11.007
P407
P577
2013-11-15T00:00:00Z